DAVE ZAMPA is a partner in Sidley’s Chicago office with more than 30 years of experience handling public and private M&A transactions, spin-offs, joint ventures and other strategic transactions. Dave focuses on transactions in the healthcare industry, and works with medical device clients, life sciences and related technology clients as well as healthcare providers and healthcare real estate and other infrastructure providers. He brings together a variety of practice areas within Sidley’s global Life Sciences practice such as food, drug and medical device regulation, compliance and enforcement, healthcare, products liability, intellectual property, competition, and privacy to serve the needs of clients around the globe.
Dave has been recognized in The Best Lawyers in America each year since 2008, in Corporate Law, with a client noting that he “is very knowledgeable, hardworking, and intelligent. Moreover, he is a pleasure to work with.”
Recent representations include:
- Gamma Biosciences – a life sciences tools platform of KKR – in several strategic investments.
- Welltower’s sale of a 48-facility senior living portfolio managed by Benchmark Senior Living to affiliates of KKR for $1.8 billion.
- Varian Medical’s further expansion into interventional oncology through its acquisitions of Endocare (cryoablation and microwave ablation); Alicon (embolic therapy); and the microsphere and bland embolic bead products of Boston Scientific.
- GE Healthcare in its investment in the IPO of Sophia Genetics, a provider of a cloud-based SaaS platform of genomic data.